Skip to main content

  • Top 11 uveitis papers for residents

    American Uveitis Society
    Uveitis

    Add to My Bookmarks

    Edited by: Justine R. Smith, MD, PhD
    American Uveitis Society AAO Education Liaison

    The following 11 uveitis papers published in 2016 were selected by members of the American Uveitis Society for their outstanding teaching value for residents:

    1. Fernandes Felix JP, Cavalcanti Lira RP, Cosimo AB, Cardeal da Costa RL, Nascimento MA, Leite Arieta CE. Trimethoprim-Sulfamethoxazole versus placebo in reducing the risk of toxoplasmic retinochoroiditis recurrences: a three-year follow-up. Am J Ophthalmol. 2016;170:176-182.
    2. Fox AR, Gordon LK, Heckenlively JR, Davis JL, Goldstein DA, Lowder CY, Nussenblatt RB, Butler NJ, Dalal M, Jayasundera T, Smith WM, Lee RW, Adamus G, Chan CC, Hooks JJ, Morgans CW, Detrick B, Sen HN. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol. 2016;168:183-90.
    3. Furtado JM, Espósito DL, Klein TM, Teixeira-Pinto T, da Fonseca BA. Uveitis associated with Zika virus infection. N Engl J Med. 2016;375:394-6.
    4. Jaffe GJ, Dick AD, Brézin AP, Nguyen QD, Thorne JE, Kestelyn P, Barisani-Asenbauer T, Franco P, Heiligenhaus A, Scales D, Chu DS, Camez A, Kwatra NV, Song AP, Kron M, Tari S, Suhler EB. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375:932-43.
    5. Jaffe GJ, Lin P, Keenan RT, Ashton P, Skalak C, Stinnett SS. Injectable fluocinolone acetonide long-acting implant for noninfectious intermediate uveitis, posterior uveitis, and panuveitis: two-year results. Ophthalmology. 2016;123:1940-8.
    6. Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Remission of intermediate uveitis: incidence and predictive factors. Am J Ophthalmol. 2016;164:110-7.e2.
    7. Lee CS, Randhawa S, Lee AY, Lam DL, Van Gelder RN. Patterns of laboratory testing utilization among uveitis specialists. Am J Ophthalmol. 2016;170:161-167.
    8. Nguyen QD, Merrill PT, Clark WL, Banker AS, Fardeau C, Franco P, LeHoang P, Ohno S, Rathinam SR, Thurau S, Abraham A, Wilson L, Yang Y, Shams N; Sirolimus study Assessing double-masKed uveitis tReAtment (SAKURA) Study Group. Intravitreal sirolimus for noninfectious uveitis: A Phase III sirolimus study assessing double-masked uveitis treatment (SAKURA). Ophthalmology. 2016;123:2413-2423.
    9. Nguyen QD, Merrill PT, Jaffe GJ, Dick AD, Kurup SK, Sheppard J, Schlaen A, Pavesio C, Cimino L, Van Calster J, Camez AA, Kwatra NV, Song AP, Kron M, Tari S, Brézin AP. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388:1183-92.
    10. Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. Cataract surgery outcomes in uveitis: The multicenter uveitis steroid treatment trial. Ophthalmology. 2016;123:183-90. 
    11. Thorne JE, Suhler E, Skup M, Tari S, Macaulay D, Chao J, Ganguli A. Prevalence of noninfectious uveitis in the United States: a claims-based analysis. JAMA Ophthalmol. 2016;134:1237-1245. 

    An American Uveitis Society Publication

    Contributors:

    Nisha Acharya, MD, MS; Stephen Anesi, MD; Meghan K. Berkenstock, MD; Nicholas J. Butler, MD; Peter Y. Chang, MD; Janet L. Davis, MD; James P. Dunn, MD; Anthony S. Ekong, MD; Lisa Faia, MD; James C. Folk, MD; K. Bailey Freund, MD; Sunir J. Garg, MD; Alla Goldberg, MD; John Gonzales, MD; Lynn K. Gordon, MD, PhD; David C. Gritz, MD, MPH; Douglas A. Jabs, MD, MBA; Daniel A. Johnson, MD; Brian C. Joondeph, MD, MPS; Kashyap B. Kansupada, MD, FACS; Henry J. Kaplan, MD; Sanjay Kedhar, MD; Jared Knickelbein, MD, PhD; Shree K. Kurup, MD; Daryl E. Kurz, MD; Paul A. Kurz, MD; Kelly L. Larkin, MD; Paul Latkany, MD; Shelly T Lee, MD; Ralph D. Levinson, MD; Ann-Marie Lobo, MD; Pauline T. Merrill, MD; Ramana S. Moorthy, MD; Deanne M. Nakamoto, MD; Ghazala AD O’Keefe, MD; Armando Oliver, MD; E. Mitchel Opremcak, MD; Alan G. Palestine, MD; Sirichai Pasadhika, MD; Parvathy A. Pillai, MD; Narsing A. Rao, MD; Russell W. Read, MD, PhD; Ashvini K. Reddy, MD; Damien C. Rodger, MD, PhD; James T. Rosenbaum, MD; Nehali V. Saraiya, MD; Vimal Sarup, MD; Shlomit Schaal, MD, PhD; Anita Schadlu, MD; Ivan R. Schwab, MD; H. Nida Sen, MD, MHS; Mark D. Sherman, MD; Jerry A. Shields, MD; Justine R. Smith, FRANZCO, PhD; Lucia Sobrin, MD, MPH; Eric B. Suhler, MD, MPH; Robert T. Swan, MD; Jennifer E. Thorne, MD, PhD; Albert T. Vitale, MD; Jonathan D. Walker, MD; R. Christopher Walton, MD; Scott M. Whitcup, MD; Susan Wittenberg, MD; Ira G. Wong, MD; Steven Yeh, MD

    Acknowledgement:

    The American Uveitis Society thanks Ms. Deb Sullivan for her administrative assistance in preparing this publication.